SCHEMBL5138853

SCHEMBL5138853

Clc1cc2ccc(Oc3ccccc3)nc2cc1-c1cn(C2CC(CN3CCC3)C2)c2ncncc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 20/20 0.43
INSR P06213 5/20 0.43
LCK P06239 4/20 0.43
KDR P35968 4/20 0.43
KIT P10721 3/20 0.43
PDPK1 O15530 3/20 0.43
RET P07949 3/20 0.43
KCNH2 Q12809 3/20 0.43
LYN P07948 2/20 0.43
FGFR1 P11362 2/20 0.43
SRC P12931 2/20 0.43
FLT1 P17948 2/20 0.43
FLT4 P35916 2/20 0.43
FLT3 P36888 2/20 0.43
ERBB4 Q15303 2/20 0.43
EGFR P00533 2/20 0.43
PDGFRA P16234 2/20 0.43
FGFR4 P22455 2/20 0.43
PIK3CG P48736 2/20 0.43
BTK Q06187 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5138051 0.86 IGF1R (0.35) IGF1RINSRLCKKDRKIT
SCHEMBL401845 0.86 IGF1R (0.59) IGF1RINSRLCKKDRKIT
SCHEMBL5138284 0.84 IGF1R (0.43) IGF1RINSRLCKKDRKIT
SCHEMBL5138129 0.80 IGF1R (0.46) IGF1RINSRLCKKDRKIT
SCHEMBL5083765 0.77 IGF1R (0.39) IGF1RINSRLCKKDRKIT
SCHEMBL402558 0.76 BTK (0.46) IGF1RINSRLCKKDRKIT
SCHEMBL19244746 0.76 IGF1R (0.61) IGF1RINSRLCKKDRKIT
SCHEMBL400064 0.75 IGF1R (0.68) IGF1RINSRLCKKDRKIT
SCHEMBL5078959 0.75 LCK (0.36) IGF1RINSRLCKKDRKIT
SCHEMBL6633259 0.74 IGF1R (0.72) IGF1RINSRLCKKDRKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979002-A2 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI Pharmaceuticals, Inc. (US) 2008-10-15 EP claimed
WO-2007075554-A2 COMBINATION OF IGFR INHIBITOR AND ANTI-CANCER AGENT OSI PHARMACEUTICALS, INC. (US) 2007-07-05 WO claimed